Navigation Links
Genedata at ESACT Announces Expansion Into Biopharma Process Development
Date:6/24/2013

Lille, France (PRWEB) June 24, 2013

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that it is extending its enterprise biologics R&D solution to support bioprocess development workflows. A first-in-class software solution for integrated biopharma data management, Genedata Biologics enables biologics companies to more efficiently discover, develop, and manufacture novel, as well as generic, biotherapeutics. Genedata Biologics provides tailored functionalities to enhance process efficiency, which complement established antibody discovery and protein engineering functionalities. Genedata Biologics will present its latest platform developments that support cell line and process development during the 23rd European Society for Animal Cell Technology (ESACT) Meeting (Lille Grand Palais; June 23 – 26).

Towards an Integrated Platform for Cell and Process Development: Significant Efficiency and Quality Gains
Genedata Biologics, an enterprise workflow system, now also supports process and cell line development units. The platform provides tools for the optimization of protein expression, purification, and analytics processes. These tools are essential for efficient and successful production of high-quality biologics for R&D and large-scale product manufacturing. Optimizing expression and purification processes requires various groups to work in a division-of-labor environment (e.g. molecular biology, cell line engineering, assays and analytics, and bioprocess development g
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
2. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
3. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
4. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
5. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
6. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
7. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
8. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
9. Genedata Screener Adopted for all Plate-based Screening by Major Pharmas
10. Genedata Screener for HCS Advances Phenotypic Screening
11. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... LONDON , July 29, 2015 ... on acquiring, rapidly developing and commercialising ... human health   Highly experienced management team; ...     Mereo BioPharma Group Ltd ... successfully raised $119m ( c. £76.5m), gross, from blue ...
(Date:7/28/2015)... Virginia (PRWEB) , ... July 29, 2015 , ... The new Xsample 530 sample ... It handles a wide range of liquid viscosities – from less than 12,000 mPas (internal ... 12 mL vials. , What immediately catches the eye about Xsample 530 is its ...
(Date:7/28/2015)... NEW YORK , July 28, 2015 ... helped by hearing aids achieved significant and sometimes profound ... hybrid cochlear implant devices, according to a new multicenter ... In the study, described online ahead of ... 10 medical centers and private clinics in ...
(Date:7/28/2015)... UK (PRWEB) , ... July 28, 2015 , ... ... reached more than EUR 1.022 billion in 2013; while production volume reached close ... the leading producing country with a share of 75.5% of the region’s total ...
Breaking Biology Technology:Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11New Moves in Automatic Sample Handling: Introducing Xsample 530 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3
... of the Edmonton technology community and its companies and prove how ... ... Edmonton, AB (PRWEB) October 27, 2008 -- Edmontonians, a ... Visionaries--Insight, Innovation, Ingenuity project with the goal of increasing ...
... complement inhibitor to be tested in AMD patients, ... a,privately held biotechnology company developing medicines for the ... the Company,will be presenting its ASaP Phase I ... the Retina Subspecialty Day at the American,Academy of ...
... Osteoporosis Medications, PHILADELPHIA, Oct. 27 People ... for serious atrial fibrillation (AF), or,irregular heartbeats, according ... 2008, the 74th annual international scientific assembly of ... people taking,alendronate or zoledronic acid, two common medications ...
Cached Biology Technology:Edmonton's Technology Community: Using Social Media to Raise Awareness 2Potentia Pharmaceuticals to Present ASaP Phase I Clinical Trial Data for POT-4 at the American Academy of Ophthalmology Annual Meeting 2Potentia Pharmaceuticals to Present ASaP Phase I Clinical Trial Data for POT-4 at the American Academy of Ophthalmology Annual Meeting 3Osteoporosis Drugs Increase Risk for Heart Problems 2
(Date:7/21/2015)... NEW YORK , July 21, 2015 /PRNewswire/ ... critical systems, as seen in the recent U.S. ... enterprises a solution to the infosec conundrum, but ... data is stored. To address this dilemma, Biometrics-as-a-Service ... of its Biometric Tokenization SDK for third party ...
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... (WSU) Laboratory for Atmospheric Research is leading a nationwide ... the distribution of natural gas. Beginning this month, ... Lamb will quantify methane emissions throughout local gas systems ... data to estimate a national methane emissions rate for ...
... the University of Michigan have identified a new potential ... alternative or complementary therapy to statins. Scientists ... Sciences Institute inhibited the action of a gene responsible ... of the liver to remove cholesterol from the blood ...
... animals are frequently observed scavenging on other animals whether it ... or a buzzard swooping down on a dead animal. However, ... difficult, and often overlooked in marine food web studies. , ... titled, " White sharks ( Carcharodon carcharias ) scavenging on ...
Cached Biology News:Methane emissions from natural gas local distribution focus of new study 2Methane emissions from natural gas local distribution focus of new study 3U-M researchers find new way to clear cholesterol from the blood 2Great white sharks 2